RN Poll: Alternative Medicine for Knee OA

The society guidelines are equivocal about the effectiveness of numerous interventions offered by non-physicians to relieve knee OA pain, such as acupuncture, transcutaneous electrical nerve stimulation, and ultrasound. What's your experience?

Which of the following do you think is most likely to be effective for knee OA pain? (Choose one)

Acupuncture
Massage therapy
Transcutaneous electrical nerve stimulation
Balneotherapy (salt or mineral baths)
None of the above
Related Videos
Timothy Ritter, MD | Credit: Texas Digestive Disease Consultants
What Are Some Other Methods To Manage Skin Cancer Outside of Biopsies?
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Julie Refardt, MD, PhD: Current Hyponatremia Clinical Interventions Sufficient
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Carla Nester, MD | Credit: HCPLive
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Related Content
AIMS65 Could Predict Treated Gastrointestinal Bleed Death, Rebleed Risks
October 27th 2024

AIMS65 Could Predict Treated Gastrointestinal Bleed Death, Rebleed Risks

Kevin Kunzmann
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 27th 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Infliximab Improves Ulcerative Colitis, Crohn's Disease Regardless of Immunosuppressants
October 27th 2024

Infliximab Improves Ulcerative Colitis, Crohn's Disease Regardless of Immunosuppressants

Kevin Kunzmann
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Jonathan Barratt, PhD | Credit: IgA Nephropathy Foundation
October 27th 2024

ORIGIN OLE Data Solidify Atacicept Disease-Modifying Potential for IgA Nephropathy

Patrick Campbell
Patient-Reported Outcomes for Roflumilast Foam Highlighted for Seborrheic Dermatitis
October 26th 2024

Patient-Reported Outcomes for Roflumilast Foam Highlighted for Seborrheic Dermatitis

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.